FDA approves TB pill that cures more hard-to treat patients

TRENTON, N.J. (AP) — U.S. regulators have approved a new tuberculosis medicine that shortens and improves treatment for the hardest-to-treat cases, a worsening problem in many poor countries.

It’s the first TB drug developed by a nonprofit group, the TB Alliance, which was formed to come up with better treatments.

The Food and Drug Administration approved pretomanid (preh-TOH’-meh-nihd) for use with two other drugs for TB, which attacks the lungs. In testing, the three-pill combo cured about 90% of patients with very drug-resistant TB, usually within 6 months. It also appears to stop patients spreading the deadly bacterial infection after just a few days’ treatment.

Until now, the best option cured about two-thirds of patients and took 18 to 30 months, according to the TB Alliance.

Associated Press

Associated Press

TOP STORIES

KBJR 6 Weather Authority

Ashland
53°
Hayward
53°
Superior
58°
Hibbing
53°
International Falls
56°
Grand Marais
50°
Ironwood
55°
Siren
Solon Springs
Munising
62°
Brainerd
55°
Bemidji
58°
Aitkin
Silver Bay
50°
Cloquet
Cook
Ely
55°
Grand Rapids
59°
Mora
Moose Lake
50°
Orr
57°
Two Harbors
Hinckley
Connect with KBJR 6
Top Stories
American Association

___ St. Paul 17, Winnipeg 5 Kansas City 6, Sioux City 3 Fargo-Moorhead 6, Gary Southshore 5 Cleburne 16, Sioux Falls 6 Texas 6, Lincoln

Read More »
American Association

___ St. Paul 17, Winnipeg 5 Kansas City at Sioux City, 7:05 p.m. Fargo-Moorhead 6, Gary Southshore 5 Cleburne at Sioux Falls, 7:05 p.m. Texas

Read More »
Scroll to top
Skip to content